Bill Gates Vaccine Feature photo
Pandemic Profiteers

Poor Nations Left Reeling After Bill Gates Advised Oxford to Ditch Open Source COVID Vaccine

Unable to secure a profit in immunizing poorer nations, Western multinationals, including Oxford’s private partner AstraZeneca, have prioritized those who can pay the most.

by Alan Macleod

Successful Not-for-Profit Oxford COVID Vaccine Threatens Big Pharma Profit Logic

“The Oxford vaccine is… striking, since the point was to pay researchers, but not to rely on patent monopolies to generate large profits.” – Economist Dean Baker

Successful Not-for-Profit Oxford COVID Vaccine Threatens Big Pharma Profit Logic

The world is abuzz today after a team of medical researchers from Oxford University in the United Kingdom announced that advanced trials of their experimental coronavirus vaccine were a roaring success,

Read Full Article

Be Sociable, Share!

Alan Macleod

Alan MacLeod is Senior Staff Writer for MintPress News. After completing his PhD in 2017 he published two books: Bad News From Venezuela: Twenty Years of Fake News and Misreporting and Propaganda in the Information Age: Still Manufacturing Consent, as well as a number of academic articles. He has also contributed to FAIR.org, The Guardian, Salon, The Grayzone, Jacobin Magazine, and Common Dreams.

You Might Also Like